BR112014006741A2 - método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial - Google Patents

método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial

Info

Publication number
BR112014006741A2
BR112014006741A2 BR112014006741A BR112014006741A BR112014006741A2 BR 112014006741 A2 BR112014006741 A2 BR 112014006741A2 BR 112014006741 A BR112014006741 A BR 112014006741A BR 112014006741 A BR112014006741 A BR 112014006741A BR 112014006741 A2 BR112014006741 A2 BR 112014006741A2
Authority
BR
Brazil
Prior art keywords
kit
specific
kidney injury
urine sample
early
Prior art date
Application number
BR112014006741A
Other languages
English (en)
Inventor
Ernesto Irarrazabal Muñoz Carlos
Original Assignee
Univ Los Andes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47913944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014006741(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Los Andes filed Critical Univ Los Andes
Publication of BR112014006741A2 publication Critical patent/BR112014006741A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

abstract the present invention relates to a method and a kit for monitoring, diagnosis, prognosis of acute kidney injury in early stage and determination of treatment in subjects suffering thereof. the method comprises the steps of a) providing a urine sample; b) enriching the urine sample in exosomes present in the urine sample using at least one step of immunopurification; c) detecting an acute kidney injury (aki) marker in the exosome. the invention also relates to a kit for determining the presence and/or level of a specific kidney injury marker, for simple and early determination of the onset of aki in a subject, the kit comprising means for enriching the urine sample in exosomes using at least one step of immunopurification, and means for detecting a predetermined kidney injury marker of a condition. the method and kit of the invention have the advantage to provide a specific, simple and early detection of kidney injury markers that is no possible with the standard methods applied until now. the method and kit of the invention also provide the advantage of identifying the specific structure that is injured in the kidney, since it uses specific antibodies for specific proteins present in specific structures of the kidney. --------------------------------------------------------------------------tradução do resumo resumo patente de invenção: "método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial". a presente invenção se refere a um método e a um kit para mo-nitorização, diagnóstico, prognóstico de lesão renal aguda no estágio inicial e determinação de tratamento em sujeitos que sofram dela. o método com-preende as etapas de a) obtenção de uma amostra de urina; b) enriqueci-mento da amostra de urina em exossomos presentes na amostra de urina usando pelo menos uma etapa de imunopurificação; c) detecção de um mar-cador de lesão renal aguda (aki) no exossomo. a invenção também se refere a um kit para determinação da presença e/ou nível de um marcador de lesão renal específico, para determinação simples e precoce do início de aki em um sujeito, o kit compreendendo meios para enriquecimento da amostra de urina em exossomos usando pelo menos uma etapa de imunopurificação, e meios para detecção de um marcador de lesão renal predeterminado de uma condição. o método e o kit da invenção têm a vantagem de proporcionarem uma detecção específica, simples e precoce de marcadores de lesão renal, o que não era possível com os métodos padronizados aplicados até agora. o método e o kit da invenção também proporcionam a vantagem de identificar a estrutura específica que está lesionada no rim, pois usam anticorpos específicos para proteínas específicas presentes em estruturas específicas do rim.
BR112014006741A 2011-09-22 2011-09-22 método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial BR112014006741A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/054187 WO2013041913A1 (en) 2011-09-22 2011-09-22 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage

Publications (1)

Publication Number Publication Date
BR112014006741A2 true BR112014006741A2 (pt) 2017-03-28

Family

ID=47913944

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006741A BR112014006741A2 (pt) 2011-09-22 2011-09-22 método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial

Country Status (14)

Country Link
US (1) US20140329334A1 (pt)
EP (1) EP2758774A4 (pt)
JP (1) JP5893742B2 (pt)
KR (1) KR20140076571A (pt)
CN (1) CN103917869A (pt)
AU (1) AU2011377379A1 (pt)
BR (1) BR112014006741A2 (pt)
CA (1) CA2849577A1 (pt)
HK (1) HK1199754A1 (pt)
IL (1) IL231626A0 (pt)
IN (1) IN2014DN03194A (pt)
MX (1) MX2014003422A (pt)
RU (1) RU2014115999A (pt)
WO (1) WO2013041913A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6297676B2 (ja) 2013-05-06 2018-03-20 日立化成株式会社 標的分子を捕捉するためのデバイス及び方法
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
US20170227541A1 (en) * 2014-07-17 2017-08-10 The Trustees Of The University Of Pennsylvania Methods for using exosomes to monitor transplanted organ status
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
US20170315134A1 (en) * 2014-11-11 2017-11-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP6631852B2 (ja) * 2014-11-12 2020-01-15 日立化成株式会社 臓器障害を診断するための方法および装置
WO2016140388A1 (ko) * 2015-03-05 2016-09-09 경북대학교 산학협력단 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법
US20160320390A1 (en) * 2015-05-01 2016-11-03 Morehouse School Of Medicine Compositions and methods for capturing exosomes
EP3334498B1 (en) 2015-08-12 2023-06-07 The Trustees of Columbia University in the City of New York Methods of treating volume depletion and kidney injury
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
JP6531987B2 (ja) * 2015-10-01 2019-06-19 国立大学法人名古屋大学 腎疾患診断のためのエクソソーム回収法
CN105441578B (zh) * 2016-01-19 2018-08-31 中南大学湘雅二医院 尿液外泌体microRNA分子标志物的应用及制备的试剂盒
US11753682B2 (en) 2016-03-07 2023-09-12 Father Flanagan's Boys'Home Noninvasive molecular controls
CN106053811A (zh) * 2016-06-05 2016-10-26 浙江大学 一种尿液外泌体elisa的检测方法及其应用
RU2647327C2 (ru) * 2016-07-05 2018-03-15 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО КубГМУ Минздрава России) Способ ранней диагностики хронической болезни почек у пациентов с хронической обструктивной болезнью легких
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法
CN109425742A (zh) * 2017-08-23 2019-03-05 迪亚莱博（张家港）生物科技有限公司 一种化学发光法快速检测水通道蛋白1的试剂盒
WO2019045049A1 (ja) * 2017-09-01 2019-03-07 学校法人帝京大学 腎尿細管細胞特異的発現ベクター
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
EP3748362B1 (en) * 2019-06-06 2023-10-11 Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz In vitro method for detecting renal disease
EP3904883A1 (en) * 2020-04-07 2021-11-03 Sciomics GmbH Prediction and early diagnosis of acute kidney injury
RU2765678C1 (ru) * 2020-12-21 2022-02-01 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования риска развития острого повреждения почек у больных с острым коронарным синдромом
CN113189321B (zh) * 2021-04-12 2024-06-25 攸太科技(台州)有限公司 一种尿液检测方法
WO2024085722A1 (ko) * 2022-10-20 2024-04-25 건국대학교 산학협력단 신장 질환의 조기 진단을 위한 바이오마커 조성물 및 이를 이용한 신장 질환의 조기 진단에 필요한 정보를 제공하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
US20050037450A1 (en) * 2002-08-06 2005-02-17 Duke University Novel targets for lithium therapy
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US8758991B2 (en) * 2006-04-26 2014-06-24 University Of Louisville Research Foundation, Inc. Isolation of membrane vesicles from biological fluids and methods of using same
CN102084000B (zh) * 2008-02-01 2016-03-16 总医院有限公司 微泡在医学疾病和病况的诊断、预后以及治疗中的用途
WO2009116021A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method of assessing kidney function in a human subject
WO2010054025A1 (en) * 2008-11-05 2010-05-14 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
CN102301002A (zh) * 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和系统
AU2009318813B2 (en) * 2008-11-21 2016-11-24 Future Medical Diagnostics Co., Ltd Methods, devices and kits for detecting or monitoring acute kidney injury
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
EP2863225B1 (en) * 2009-05-18 2016-12-07 Washington University Methods of renal cancer detection using adipose differentiation related protein (ADFP) as biomarker

Also Published As

Publication number Publication date
CN103917869A (zh) 2014-07-09
EP2758774A4 (en) 2015-04-29
IL231626A0 (en) 2014-05-28
EP2758774A1 (en) 2014-07-30
RU2014115999A (ru) 2015-10-27
KR20140076571A (ko) 2014-06-20
HK1199754A1 (en) 2015-07-17
US20140329334A1 (en) 2014-11-06
IN2014DN03194A (pt) 2015-05-22
CA2849577A1 (en) 2013-03-28
JP2014528076A (ja) 2014-10-23
AU2011377379A1 (en) 2014-04-10
WO2013041913A1 (en) 2013-03-28
JP5893742B2 (ja) 2016-03-23
MX2014003422A (es) 2014-10-13

Similar Documents

Publication Publication Date Title
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
MX2018008421A (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
ATE452343T1 (de) Verbesserte vitamin-d-messung
AU2018260845A1 (en) Evaluation and treatment of bradykinin-mediated disorders
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
NZ599105A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BR112013027867A2 (pt) "método de detectar o nível de um anticorpo anti-ip10 em amostra, anticorpo monoclonal isolado ou porção de ligação de antígeno do mesmo, linhagem de célula de hibridoma e kit"
BR112012009855A2 (pt) métodos para determinar uma quantidade eficaz de uma droga, para otimizar a terapia e/ou reduzir as toxicidade a uma droga, para determinar a presença ou nível de uma droga, para otimizar a quantidade terapêutica de uma droga e para determinar a presença ou nível de um autoanticorpo para uma droga, e, kit
WO2014201516A3 (en) Biomarker identification
BR112015021199A2 (pt) método para determinar se uma infeção é bacteriana e/ou viral, dispositivo de fluxo lateral para detecção de um analito em uma amostra, e, dispositivo para detecção de um marcador bacteriano e/ou viral em uma amostra
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
EA201290711A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
BR112013021963A2 (pt) sistema e método de separação de sangue para uma tira de teste seca
PH12020551371A1 (en) Assays to detect neurodegeneration
WO2008097773A8 (en) Methods and devices for diagnosis of appendicitis
JP2017505897A5 (pt)
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
MD3171174T2 (ro) Lactoferină pentru utilizarea în diagnosticul sau prognosticul bolii Alzheimer
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2012139052A3 (en) Antibody biomarkers for diabetes
RU2013158667A (ru) Способ диагностики болезни гоше
BR112016017901A2 (pt) ensaio inovador para detectar periostina humana

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]